Development of 16S rRNA-based probes for the identification of Gram-positive anaerobic cocci isolated from human clinical specimens  by Wildeboer-Veloo, A.C.M. et al.
ORIGINAL ARTICLE 10.1111/j.1469-0691.2007.01803.x
Development of 16S rRNA-based probes for the identiﬁcation of
Gram-positive anaerobic cocci isolated from human clinical specimens
A. C. M. Wildeboer-Veloo, H. J. M. Harmsen, G. W. Welling and J. E. Degener
Department of Medical Microbiology, University Medical Center Groningen, University of Groningen,
Groningen, The Netherlands
ABSTRACT
Fluorescent probes targeted at 16S rRNA were designed for Peptostreptococcus anaerobius and
Peptostreptococcus stomatis (Pana134), Parvimonas micra (Pamic1435), Finegoldia magna (Fmag1250),
Peptoniphilus asaccharolyticus (Pnasa1254), Peptoniphilus ivorii (Pnivo731), Peptoniphilus harei (Pnhar1466),
Anaerococcus vaginalis (Avag1280) and Anaerococcus lactolyticus (Alac1438), based on the 16S rRNA
sequences of reference strains and 88 randomly chosen clinical isolates. These strains were also used for
validation of the probes. Application of the probes to an additional group of 100 clinical isolates revealed
that 87% of Gram-positive anaerobic cocci (GPAC) could be identiﬁed with this set of probes. The 16S
rRNAs of 13 clinical isolates that could not be identiﬁed were sequenced. Most of these isolates were
GPAC that were not targeted by the probes. No clinical isolates of Pn. asaccharolyticuswere encountered.
Near full-length sequences were obtained from 71 of 101 (n = 88 + 13) sequenced clinical isolates. Of
these, 25 showed <98% similarity with the homologues of the closest established species. The Fmag1250,
Pamic1435, Pnhar1466, Pana134, Pnasa1254 and Pnivo731 probes allowed reliable identiﬁcation and
hybridised with all corresponding isolates. The Avag1280 and Alac1438 probes failed to hybridise with
two isolates and one isolate, respectively, because of intra-species variation. However, overall, the set of
probes yielded fast and reliable identiﬁcation for the majority of clinical isolates.
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INTRODUCTION
Gram-positive anaerobic cocci (GPAC) are part of
the commensal microbiota of humans at different
sites of the body, and are also known to be
important in human disease. They account for
about one-third of the anaerobic isolates recov-
ered from clinical material [1]. During the last
decade, the taxonomy of GPAC has changed
substantially [2–4]. Peptostreptococcus productus
was transferred to the genus Ruminococcus [5],
and the genus Peptostreptococcus was divided into
six new groups [6,7]. Murdoch and Shah [7]
transferred the species Peptostreptococcus micros
and Peptostreptococcus magnus to two new genera,
Micromonas and Finegoldia, respectively, with each
being the only species present in their respective
genus. The genus Micromonas has now been
replaced by Parvimonas, with Parvimonas micra
(formerly Micromonas micros) being the only
species in the genus [8]. Ezaki et al. [6] divided
the remaining peptostreptococci into three phy-
logenetic groups, Peptoniphilus gen. nov., Anaero-
coccus gen. nov. and Gallicola gen. nov., with
Gallicola barnesae being the only species present in
the latter genus. The type species of the two other
new genera are Peptoniphilus asaccharolyticus and
Anaerococcus prevotii, respectively. The only spe-
cies remaining in the genus Peptostreptococcus are
Peptostreptococcus anaerobius and a recently de-
scribed species, Peptostreptococcus stomatis, iso-
lated from the human oral cavity [9].
Infections involving GPAC are often poly-
microbial [10]. The GPAC isolated most com-
monly from infections are P. anaerobius, Pa. micra,
Finegoldia magna and Pn. asaccharolyticus [11].
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However, although these anaerobic cocci are
isolated commonly from infections, little attention
is paid to their detection and identiﬁcation in
diagnostic laboratories because of cumbersome
and inadequate classiﬁcation systems. The
phenotypic identiﬁcation of GPAC is based on
morphological appearance, carbohydrate forma-
tion and the use of gas–liquid chromatography
[12]. The availability of proteolytic enzyme pro-
ﬁles made identiﬁcation of the acknowledged
GPAC easier and reproducible [13]. This contrib-
uted to the development of several commercial
identiﬁcation kits, including the RapID ANA
(Innovative Diagnostic Systems, Atlanta, GA,
USA) and Rapid ID 32A (bioMe´rieux, Basing-
stoke, UK) systems. However, the newly
described species have not yet been included in
the databases of these kits. In addition, several
new species, assigned originally to the genus
Peptostreptococcus, have been described, e.g.,
Peptoniphilus harei, Peptoniphilus ivorii and Anaero-
coccus octavius [14]. The clinical relevance of these
new species has not yet been assessed.
The availability of genotypic data now makes
it possible to develop molecular techniques for
the detection and identiﬁcation of GPAC. Song
et al. [15] evaluated the use of 16S rRNA
sequences to identify GPAC. These authors were
able to identify 84% of clinical isolates of GPAC
by comparison with their own sequence database
of type strains. These sequences revealed ambig-
uous data in public databases. Song et al. [16]
developed a multiplex PCR assay for the rapid
identiﬁcation of GPAC, using genus- and species-
speciﬁc primers. Riggio et al. [17–19] developed
additional molecular detection assays for GPAC,
including a PCR method for the detection of
F. magna and Pa. micra in oral clinical specimens,
and a PCR–restriction fragment length polymor-
phism assay of 16S rRNA genes for the identiﬁ-
cation of oral Peptostreptococcus isolates. DNA
probes have also been used for the identiﬁcation
of Pa. micra [20] and P. anaerobius [21]. Ampliﬁ-
cation of the 16S)23S intergenic spacer region
was used by Hill et al. [22] to differentiate among
different species of the former peptostreptococci.
When the banding patterns of 38 test strains were
compared with those of reference strains, fewer
than half of the strains were identiﬁed. The
remaining strains could not be identiﬁed, either
because of intra-species variation or because they
differed signiﬁcantly from the type strain.
GPAC have also been detected using PCR in
faecal samples [23], and have been quantiﬁed
using ﬂuorescent in-situ hybridisation [24]. The
latter technique makes it possible to detect and
identify GPAC in pure culture, and perhaps
also directly in clinical specimens. This tech-
nique is relatively inexpensive to perform, and
can be implemented easily in routine diagnostic
laboratories. The present report describes the
design and validation of 16S rRNA-based
probes for the detection and identiﬁcation of
clinically relevant GPAC. Probes were designed
for a selection of GPAC isolated in our labora-
tory, namely, P. anaerobius ⁄ stomatis, Pa. micra,
F. magna, Pn. asaccharolyticus, Anaerococcus vagi-
nalis, Anaerococcus lactolyticus, Pn. ivorii and
Pn. harei.
MATERIALS AND METHODS
Strains
Reference strains and clinical isolates were cultured on Brucella
blood agar anaerobic plates and incubated in an anaerobic
atmosphere for 48 h at 37C. Cells were harvested and ﬁxed
for ﬂuorescent in-situ hybridisation analyses in 1:1 phosphate-
buffered saline (8 g of NaCl, 0.2 g of KCl, 1.44 g of Na2HPO4
and 0.24 g of KH2PO4 ⁄L) and ethanol 96% v ⁄v. Fixed cells
were stored at )20C. In total, 188 random clinical isolates of
GPAC were obtained from the diagnostic laboratory of the
University Medical Center, Groningen, and the Regional
Public Health Laboratory, Enschede, The Netherlands. The
original clinical samples were obtained from a variety of
anatomical sites, e.g., abdomen, head ⁄neck area, leg, arm and
groin. Only one isolate of each species from a single patient
was included in the study. The isolates were identiﬁed
phenotypically using the Rapid ID 32A system and the
Wadsworth manual [12]. Isolates that could not be identiﬁed,
or only ambiguously, were designated as GPAC. Pheno-
typically, Pn. asaccharolyticus can be distinguished from
Pn. harei only by colony form and cell morphology [12]. Since
this is difﬁcult to achieve, these organisms were designated
Pn. asaccharolyticus ⁄ harei.
16S rRNA gene sequencing
The 16S rRNA genes of 88 randomly chosen clinical isolates
were sequenced. DNA was isolated as described previously
[25] and the 16S rRNA genes were ampliﬁed and sequenced
using universal 16S rRNA-speciﬁc primers [26]. The resulting
sequences were aligned with sequences of reference strains
derived from the EMBL database and the Ribosomal Data-
base Project [27], using ARB software [28]. Similarities of the
sequences were calculated using a DNA distance matrix
embedded in BioEdit (http://www.mbio.ncsu.edu/BioEdit/
bioedit.html). The Escherichia coli sequence for positions
82–1371 was included to ensure accurate determination of
species similarity. A phylogenetic tree of sequences that had
<98% similarity with their closest relative was constructed
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using the same alignment by the neighbour-joining method
with Jukes Cantor correction, based on a distance matrix that
only included positions with >50% conservation and parsi-
mony, implemented in the ARB software. As a control, the
phylogenetic tree was also calculated using the maximum-
parsimony and maximum-likelihood methods. The topology
of the tree was calculated following bootstrap analyses of
1000 replicate trees. Sequences with <98% similarity were
deposited in the EMBL database and assigned accession
numbers.
Probe design
Probes (Table S1, see Supplementary material) were designed
using the sequences of clinical isolates and reference strains
present in the Ribosomal Database Project [27] and EMBL
database. ARB software was used for alignment and probe
design [28]. When necessary, unlabelled helper nucleotides
(Table S2, see Supplementary material) were designed to
increase the in-situ accessibility of 16S rRNA, as described
by Fuchs et al. [29]. For practical purposes, probes were
designed to have a similar hybridisation temperature. All
probes were labelled with ﬂuorescein-5-isothiocyanate at the 3¢
and 5¢ ends and were synthesised by Eurogentec (Seraing,
Belgium).
Validation
Ethanol-ﬁxed cells were spotted on a slide and ﬁxed for a
further 10 min using ethanol 96% v ⁄v. Hybridisations were
performed at 50C in hybridisation buffer (0.9 M NaCl,
20 mM Tris-HCl, pH 7.2, SDS 0.1% w ⁄v) containing 10 ng of
probe, as described previously [30]. For the Pana134,
Pivo731 and Avag1280 probes (Table S1), 5 ng of the
appropriate helper nucleotides (Table S2) were added to
the hybridisation mixture. Hybridisations were performed
overnight. The bacterial probe EUB338 [31] served as a
positive control, and its complement non-EUB338 [32] as the
negative control. The speciﬁcities of the Pana134 and
Pnasa1254 probes were increased by adding formamide
20% v ⁄v, which is a duplex-destabilising agent, to the
hybridisation buffer. The hybridisation signal obtained with
the species-speciﬁc probes was compared visually with the
EUB338 and non-EUB338 signals, using an Epiﬂuorescence
BH2 microscope (Olympus, Hamburg, Germany), and scored
negative or positive. Strains of F. magna, A. vaginalis and
Pn. ivorii were permeabilised with proteinase K (500 mg ⁄L;
50 mM Tris-HCl, pH 7.6). The cell spots were covered with
the proteinase K solution and incubated for 10 min at room
temperature. The enzymic reaction was stopped by incubat-
ing the slides in ethanol 96% v ⁄v for 2 min. All probes were
validated against the reference strains and sequenced clinical
isolates listed in Table 1. In order to assess the proportion of
GPAC that could be identiﬁed, the set of species-speciﬁc
probes was also applied to an additional group of 100
clinical isolates.
RESULTS
The set of probes used in this study demonstrated
100% speciﬁcity when validated against the
reference strains listed in Table 1. F. magna,
A. vaginalis and Pn. ivorii required permeabilisa-
tion with proteinase K before hybridisation. All
other strains hybridised successfully without
additional treatment. The probes were also vali-
dated against a further set of 88 sequenced clinical
isolates (Table 2) and were shown to be 100%
speciﬁc.
The set of probes was then applied to an
additional group of 100 clinical isolates that had
been identiﬁed phenotypically (Table 3). The
majority (29%) of the isolates was identiﬁed as
F. magna on the basis of both genotypic and
phenotypic characteristics. The Pamic1435 probe
hybridised with 28% of the clinical isolates.
Three of these isolates were misidentiﬁed phe-
notypically as F. magna; one could not be iden-
tiﬁed.
The Pana134 probe hybridised with 4% of the
clinical isolates, all identiﬁed phenotypically as
P. anaerobius. The weak hybridisation signal with
this probe was increased by adding the unlabelled
helper nucleotides H115 and H155 (Table S2). The
Pnhar1466 probe hybridised with 17% of the
clinical isolates, four of which were misidentiﬁed
phenotypically, one as Peptoniphilus indolicus, and
three that could not be identiﬁed according to the
current identiﬁcation scheme. Of all isolates, 6%
were identiﬁed genotypically as Pn. ivorii, with
four isolates phenotyped correctly and two incor-
rectly. The Avag1280 probe hybridised with two
(2%) clinical isolates, which was in agreement
with the phenotypic identiﬁcation. The hybridi-
sation signal of the Pnivo731 and Avag1280
probes was increased using the helper nucleotides
H716 + H750 and H1263 + H1299, respectively
(Table S2). The Alac1438 probe hybridised with
one of the clinical isolates (1%) that could not be
identiﬁed phenotypically.
Overall, the set of probes allowed identiﬁcation
of 87% of the GPAC isolates (Table 3). The 16S
rRNA genes of the remaining 13 isolates were
sequenced to determine whether the new probes
had hybridised correctly. The sequence results
revealed two isolates of Peptococcus niger, two of
A. vaginalis, one of A. lactolyticus and one of
Sarcina ventriculi. Of these six isolates, one of the
A. vaginalis isolates was misidentiﬁed phenotyp-
ically as Peptoniphilus lacrimalis, and the A. lacto-
lyticus isolate was misidentiﬁed as F. magna. The
four other isolates were identiﬁed correctly using
the phenotypic system. Seven remaining isolates
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could not be identiﬁed phenotypically; sequence
analysis revealed three Atopobium parvulum, one
Anaerococcus tetradius, one Pn. octavius and one
Bacterium N14-24. One isolate could not be iden-
tiﬁed because ampliﬁcation of the 16S rRNA gene
was unsuccessful. Sequence analysis of the 16S
rRNA genes of the A. vaginalis and A. lactolyticus
isolates revealed that the corresponding probes
failed to hybridise with these isolates because of
mismatches. The A. lactolyticus isolates had one
mismatch with the Alac1438 probe and the two
A. vaginalis isolates had one and three mis-
matches, respectively.
Table 1. Reference strains and
sequenced clinical isolates used for
validation of the species-speciﬁc
probes for Gram-positive anaerobic
cocci
Strain
Probe
Fmag
1250
Mmic
1435
Pnhar
1466
Pana
134a,b
Avag
1280b
Alac
1438
Pnivo
731b
Pnasa
1254a
Finegoldia magna DSM 20470Tc + – – – – – – –
Parvimonas micra DSM 20468T – + – – – – – –
Peptoniphilus harei DSM 10020T – – + – – – – –
Peptostreptococcus anaerobius DSM 2949T – – – + – – – –
Anaerococcus vaginalis DSM 7457Tc – – – – + – – –
Anaerococcus lactolyticus DSM 7456T – – – – – + – –
Peptoniphilus ivorii DSM 10022Tc – – – – – – + –
Peptoniphilus asaccharolyticus DSM 20463T – – – – – – – +
Anaerococcus prevotii DSM 20548T – – – – – – – –
Anaerococcus tetradius MMBd – – – – – – – –
Peptoniphilus indolicus DSM 20464T – – – – – – – –
gpac218e – – – – – – – –
gpac053 – – – – + – – –
gpac032 + – – – – – – –
gpac127 – – – – – – – –
Clostridium sporosphaeroides DSM 1294T ND ND – ND ND ND ND ND
Dermabacter hominis DSM 7083T ND ND – ND ND ND ND ND
Clostridium colinum DSM 6011T ND ND ND – ND ND ND ND
Eubacterium tenue DSM 20695T ND ND ND – ND ND ND ND
Clostridium glycolicum DSM 1288T ND ND ND – ND ND ND ND
Clostridium difﬁcile DSM 1296T ND ND ND – ND ND ND ND
Proteus mirabilis MMB ND ND ND ND – ND ND ND
Enterococcus moraviensis DSM 15919T ND ND ND ND ND – ND ND
Clostridium beijerinckii MMB ND ND ND ND ND ND – ND
aTo increase speciﬁcity of the hybridisation, formamide 20% v ⁄v was added to the hybridisation buffer.
bUnlabelled helper nucleotides were added to the hybridisation mixture to increase the in-situ accessibility of the
16S rRNA.
cBefore hybridisation, cells were permeabilised with proteinase K 500 mg ⁄L for 10 min at room temperature.
dAll MMB strains are clinical isolates identiﬁed by routine procedures.
eAll gpac strains are sequenced clinical isolates used in this study.
DSM, Deutsche Sammlung von Mikrooganismen und Zellkulturen (Braunschweig, Germany); ND, not determined.
Table 2. Validation of the newly designed probes against
88 clinical isolates, the 16S rRNA gene sequences of which
were used for the design of the probes
Species name
Identiﬁcation (n)
Sequence Probe
Finegoldia magna 26 26
Parvimonas micra 13 13
Peptoniphilus harei 16 16
Anaerococcus lactolyticus 7 7
Anaerococcus vaginalis 6 5
Peptoniphilus ivorii 5 5
Peptostreptococcus anaerobius 5 5
Peptoniphilus lacrimalis 3
Anaerococcus tetradius 1
Anaerococcus hydrogenalis 1
Peptococcus niger 1
Atopobium parvulum 2
Ruminococcus gnavus 1
Peptostreptococcus sp. E3_32 1
Table 3. Application of the species-speciﬁc probes to 100
clinical isolates identiﬁed phenotypically
Probe identiﬁcation (n)
Phenotypic
identiﬁcation (n)
Sequence
identiﬁcation (n)
Finegoldia magna (29) F. magna (29)
Parvimonas micra (28) Pa. micra (24)
F. magna (3)
GPAC (1)
Peptoniphilus harei (17) Peptoniphilus
asaccharolyticus ⁄
harei (13)
Peptoniphilus
indolicus (1)
GPAC (3)
Anaerococcus lactolyticus (1) GPAC (1)
Anaerococcus vaginalis (2) A. vaginalis (2)
Peptoniphilus ivorii (6) Pn. ivorii (4)
GPAC (2)
Peptostreptococcus
anaerobius (4)
P. anaerobius (4)
Not identiﬁed (13) Peptococcus niger (2) Pc. niger (2)
A. vaginalis (1) A. vaginalis (1)
Pn. lacrimalis (1) A. vaginalis (1)
F. magna (1) A. lactolyticus (1)
Sarcina ventriculi (1) S. ventriculi (1)
GPAC (7) Atopobium parvulum (3)
Anaerococcus tetradius (1)
Peptoniphilus octavius (1)
Not identiﬁed (1)
Bacterium N14-24 (1)
GPAC, Gram-positive anaerobic cocci.
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A distance matrix was calculated from all
sequence results with a near complete full-length
sequence. Partially determined sequences were
suitable for probe design, but not for phylogenetic
analysis. Near full-length sequences were ob-
tained for 71 isolates, of which 25 showed <98%
similarity with their closest established species
(Table 4). Using these sequences, a phylogenetic
tree was constructed. The calculation was per-
formed using three different tree construction
methods, each of which gave the same result for
the signiﬁcant branchings. The phylogenetic tree
obtained using the neighbour-joining method is
shown in Fig. 1. All sequences of F. magna, P. an-
aerobius, A. tetradius, At. parvulum, Pc. niger, Ru-
minococcus gnavus and Bacterium N14-24 showed
‡98% similarity to the corresponding reference
strains, while more than half of the sequences of
Pa. micra showed <98% similarity to the reference
strain. In addition, some sequences of Pn. harei,
A. vaginalis and Pn. lacrimalis showed <98% sim-
ilarity to their respective closest established spe-
cies. All sequences of Pn. ivorii, A. lactolyticus,
Anaerococcus hydrogenalis and Peptostreptococcus
sp. E3_32 showed <98% similarity to the corre-
sponding reference strains.
DISCUSSION
In total, 188 isolates of GPAC were analysed in
this study, using 16S rRNA-targeted probes
and ⁄ or sequencing of the 16S rRNA gene to
obtain a genotypic identiﬁcation. Cell morphol-
ogy is used as an initial ﬁrst step in the identi-
ﬁcation of GPAC; however, the results are not
always unambiguous, as illustrated by the
sequence results (Tables 2 and 3), which revealed
the presence of At. parvulum, which is actually a
coccobacillus similar to Slackia heliotrinreducens.
The GPAC encountered most frequently were
F. magna (29%), Pa. micra (22%), Pn. harei (18%),
Pn. ivorii (6%), A. vaginalis (5%), A. lactolyticus
(5%) and P. anaerobius ⁄ stomatis (5%). Pn. asacch-
arolyticus was not observed, although previous
studies have reported that this is one of the most
frequently encountered GPAC in infections [11].
This is probably because Pn. asaccharolyticus can
be phenotypically distinguished from Pn. harei
only by its colony form and cell morphology
[12]. The present data suggest that Pn. harei has
Table 4. Similarity of the 16S rRNA sequences of clinical
isolates to those of reference strains, calculated using the
DNA distance matrixa
Species
Similarity
‡98% (n) <98% (n) Total (n)
Finegoldia magna 19 0 19
Parvimonas micra 3 7 10
Peptoniphilus harei 7 4 11
Peptoniphilus ivorii 0 3 3
Peptostreptococcus anaerobius 3 0 3
Anaerococcus lactolyticus 0 7 7
Anaerococcus vaginalis 4 1 5
Peptoniphilus lacrimalis 1 1 2
Anaerococcus tetradius 2 0 2
Atopobium parvulum 4 0 4
Peptococcus niger 1 0 1
Ruminococcus gnavus 1 0 1
Bacterium N14-24 1 0 1
Peptostreptococcus sp. E3_32 0 1 1
Anaerococcus hydrogenalis 0 1 1
aOnly sequencing experiments that yielded a near full-length sequence were
included in this analysis.
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Fig. 1. Phylogenetic tree showing the relationship between
Gram-positive anaerobic cocci and clinical isolates (shown
in bold) with <98% similarity to their closest relative. The
percentages of similarity are indicated. The neighbour-
joining tree was constructed using an alignment corre-
sponding to Escherichia coli base-pair positions 82–1371.
Only bootstrap values >90% are shown. The bar indicates
10% sequence divergence. Note: Peptostreptococcus sp.
E3_32 should be renamed Peptoniphilus sp. E3_32.
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probably been misidentiﬁed as Pn. asaccharo-
lyticus in the past. Of all the GPAC analysed,
18% were identiﬁed genotypically as Pn. harei,
indicating that this is clearly a clinically relevant
species that can be isolated from a variety of sites,
as also suggested by Song et al. [16], who identi-
ﬁed 48 (25%) of 190 isolates as Pn. harei. In the
present study, 17 isolates were identiﬁed as
Pn. harei by phenotypic methods, most of them
as Pn. asaccharolyticus ⁄ harei. One isolate was mis-
identiﬁed as Pn. indolicus and three isolates could
not be identiﬁed. The four isolates identiﬁed with
the Pana134 probe were identiﬁed phenotypically
as P. anaerobius. All strains of F. magna were
correctly identiﬁed on the basis of phenotypic
characteristics. In contrast, A. lactolyticus strains
were either misidentiﬁed as F. magna, or could
not be identiﬁed. Most of the Pn. ivorii, Pa. micra
and A. vaginalis strains were also correctly iden-
tiﬁed phenotypically.
Several technical problems required resolution.
First, the Pana134, Pnivo731 and Avag1280 probes
initially gave a weak hybridisation signal. Fuchs
et al. [29] reported that the inclusion of unlabelled
helper oligonucleotides during hybridisation
could increase the in-situ accessibility of 16S
rRNA. The use of unlabelled helper oligonucleo-
tides that bind adjacent to the probe target site
(Table S2) was successful in increasing the hy-
bridisation signal. Second, the initial
hybridisation results with F. magna, A. vaginalis
and Pn. ivorii showed no signal for EUB338 and
the speciﬁc probes. This was resolved by treating
these large cocci with proteinase K to increase
permeabilisation before hybridisation. Thus, con-
sideration of cell morphology may faci-
litate the selection of probes for hybridisation:
for large cocci, the Fmag1250, Avag1280 and
Pnivo731 probes should be used; for middle-sized
cocci, the probes Pnasa1254, Alac1438 and
Pnhar1466; for small cocci, the Pamic1435 probe;
and for cocci in chains, the Pana134 probe.
However, it is also possible to use the complete
set of probes.
The Avag1280 and Alac1438 probes failed
to hybridise with some of the corresponding
isolates, and analysis of the sequence data revealed
mismatches of the probes with the clinical
isolates. Hill et al. [22] revealed the heterogeneity
of GPAC by analysis of 16S)23S intergenic rRNA
polymorphisms, demonstrating a considerable
intra-species variation for A. vaginalis, while all
members of Pn. ivorii produced identical banding
patterns. Analysis of the sequence data from the
present study conﬁrmed the intra-species varia-
tion demonstrated by Hill et al. [22], and revealed,
in particular, that the A. lactolyticus group showed
extensive heterogeneity in 16S rRNA sequences.
When designing species-speciﬁc probes for spe-
cies with such heterogeneity, the probability
exists that probes will be restricted in speciﬁcity
and may have mismatches with the correspond-
ing isolates. Attempts were made to overcome
this by including the sequences of clinical isolates
in the probe design, and this was successful for
most of the newly designed species-speciﬁc
probes. Only the Avag1280 and Alac1438 probes
showed mismatches with corresponding isolates.
Among the 71 isolates for which a nearly full-
length sequence was obtained, 25 had <98%
similarity to the closest established species. This
is probably because of the intra-species variation
within GPAC, but such isolates might also be
considered as belonging to new species.
Since the newly designed probes were vali-
dated and directed against Gram-positive bacte-
ria, all hybridisations were performed overnight
to obtain an optimal hybridisation signal. A
shorter hybridisation time (2 h) is also possible,
although the hybridisation signal for some
GPAC will be less detectable than that after
overnight hybridisation. With the current probe
set, 87% of all GPAC isolates were identiﬁed
quickly and reliably. These probes make it
possible to differentiate Pn. asaccharolyticus from
Pn. harei, which is difﬁcult with phenotypic
methods. The probe-based identiﬁcation method
is more reliable than phenotypic methods, espe-
cially for Pn. harei, Pn. ivorii and A. lactolyticus.
Moreover, the cost of phenotypic methods is
higher than that of ﬂuorescent in-situ hybridisa-
tion. The probes also have the potential for direct
application to clinical material in order to pro-
vide fast and direct detection without costly
anaerobic cultivation.
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SUPPLEMENTARY MATERIAL
The following Supplementary material is available
for this article online at http://www.blackwell-
synergy.com:
Table S1. Species-speciﬁc probes for the
detection and identiﬁcation of Gram-positive
cocci, showing sequence alignment for the target
sites
Table S2. Unlabelled helper nucleotides used in
combination with species-speciﬁc probes to in-
crease the in-situ accessibility of the 16S rRNA
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